Retrospective analysis of real-world outcomes supports the use of the Amplatzer cardiac plug for left atrial appendage closure in atrial fibrillation patients with a very high risk of stroke or serious bleeds and who cannot tolerate oral anticoagulation.
When patients have a defibrillator implated they have many concerns about their overall health, including how it affects their sex life. Research has shown the importance of doctors and their patients working together through these issues.
Analyses of patient records indicate that obesity increases the risk of recurrence among patients who undergo ablation for atrial fibrillation but suggest that sustained weight loss can reduce the risk.
Injecting globs of a biopolymer based on brown algae into the heart muscle of patients with advanced heart disease helped halt or reverse disease. The procedure is meant to thicken the ventricle wall. That reduces pumping stress.
An investigational drug called andexanet alfa that can reverse the anticoagulant effects of FXa inhibitors met all primary and secondary efficacy endpoints, researchers said in a late-breaking clinical trial report at the AHA meeting in Orlando.